Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05817214
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-04-05
Brief Title:
Cadonilimab Plus Anlotinib for RMP Cervical Cancer
Sponsor:
Zhongnan Hospital
Organization:
Zhongnan Hospital
Organization Data
Organization:
Zhongnan Hospital
Class:
OTHER
Study ID:
CC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhongnan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Hui Qiu
Responsible Party Title:
Chief of Department of Radiation and Medical Gynecologic Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Zhongnan Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Akeso Biopharma Co Ltd | UNKNOWN |